全文获取类型
收费全文 | 487篇 |
免费 | 63篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 19篇 |
妇产科学 | 16篇 |
基础医学 | 72篇 |
口腔科学 | 5篇 |
临床医学 | 78篇 |
内科学 | 91篇 |
皮肤病学 | 3篇 |
神经病学 | 34篇 |
特种医学 | 7篇 |
外科学 | 61篇 |
综合类 | 26篇 |
预防医学 | 46篇 |
眼科学 | 6篇 |
药学 | 27篇 |
中国医学 | 1篇 |
肿瘤学 | 55篇 |
出版年
2023年 | 13篇 |
2022年 | 10篇 |
2021年 | 17篇 |
2020年 | 16篇 |
2019年 | 23篇 |
2018年 | 24篇 |
2017年 | 24篇 |
2016年 | 17篇 |
2015年 | 17篇 |
2014年 | 14篇 |
2013年 | 25篇 |
2012年 | 28篇 |
2011年 | 36篇 |
2010年 | 13篇 |
2009年 | 12篇 |
2008年 | 33篇 |
2007年 | 27篇 |
2006年 | 26篇 |
2005年 | 25篇 |
2004年 | 15篇 |
2003年 | 25篇 |
2002年 | 12篇 |
2001年 | 5篇 |
1999年 | 5篇 |
1998年 | 6篇 |
1997年 | 6篇 |
1996年 | 4篇 |
1995年 | 5篇 |
1994年 | 5篇 |
1991年 | 3篇 |
1990年 | 3篇 |
1989年 | 5篇 |
1988年 | 6篇 |
1987年 | 2篇 |
1986年 | 2篇 |
1985年 | 3篇 |
1984年 | 5篇 |
1983年 | 5篇 |
1982年 | 2篇 |
1980年 | 2篇 |
1979年 | 2篇 |
1978年 | 6篇 |
1976年 | 3篇 |
1974年 | 2篇 |
1972年 | 2篇 |
1965年 | 1篇 |
1964年 | 1篇 |
1962年 | 1篇 |
1960年 | 1篇 |
1952年 | 1篇 |
排序方式: 共有555条查询结果,搜索用时 0 毫秒
1.
W W Dressler G A Grell P N Gallagher F E Viteri 《American journal of public health》1988,78(6):714-716
A study of social factors and blood pressure was conducted in a Jamaican community among a sample of 199 persons ages 30 to 50. After controlling for obesity, age, and respondent tension (and other covariates), interaction effects of social class x sex for systolic and diastolic blood pressure were found. Blood pressure increased with increasing social class for males and decreased with increasing social class for females. 相似文献
2.
Susceptibility to beta-lactam antibiotics and production of beta-lactamase inBacteroides fragilis 总被引:1,自引:0,他引:1
Barbro Olsson Kathrine Dornbusch Carl-Erik Nord 《Medical microbiology and immunology》1977,163(3):183-194
Using the agar dilution technique, 231 strains of Bacteroides fragilis, isolated during a 2-year period from human infections, were identified at subspecies level and were tested for susceptibility to 13 beta-lactam antibiotics. The penicillins were benzylpenicillin, ampicillin, carbenicillin, cloxacillin, and the recently described penicillin derivatives cyclacillin, ticarcillin, and PC-904. The following cephalosporin derivatives were tested: cephaloridine, cephalothin, cephalexin, cefamandole and cefuroxime. The cephamycin C derivative cefoxitin was also included in the study. Cefoxitin was the most effective drug tested since more than 80% of the strains were inhibited by 8 microgram/ml or less, and no strain had a minimal inhibitory concentration (MIC) of more than 64 microgram/ml. There was no marked difference in sensitivity among the subspecies with exception of subspecies vulgatus, which was slightly more sensitive to all antibiotics tested. The size of the inoculum was an important factor for obtaining reproducible results in the sensitivity tests. Increased inocula resulted in markedly higher MICs for cephaloridine and cefuroxime. Production of beta-lactamase was performed on all isolates by a chromogenic cephalosporin substrate and about 90% of the strains were found to be beta-lactamase producers. 相似文献
3.
Joachim Saloga Gideon Lack Kathrine Bradley Harald Renz Gary Larsen Donald Y. M. Leung Erwin W. Gelfand 《European journal of immunology》1994,24(12):3140-3147
We investigated the ability of staphylococcal enterotoxin B (SEB) to modify the immediate hypersensitivity response induced in BALB/c mice following sensitization to ovalbumin (OVA), a response mediated by OVA-reactive Vβ8 T cells. Mice were sensitized by skin painting with OVA every second day over a period of 2 weeks. SEB, a potent activator of Vβ8+ T cells, was administered at the same site where OVA was applied (skin of the lower abdomen) following two different protocols. In protocol (A) SEB was injected intradermally 1 day before painting with OVA and on day 7; in protocol B, SEB was injected each time OVA was applied to the skin (eight times). SEB (but not SEA) altered the development of immediate hypersensitivity to OVA, as demonstrated by the reduction in allergen-specific IgE, decreased OVA-specific immediate skin test responsiveness, and prevented the development of increased airways responsiveness after bronchial challenge with OVA. Injections of SEB did not alter the proliferative responses of local draining lymph node cells or spleen mononuclear cells to OVA, indicating that administration of SEB did not inhibit the sensitization to OVA, but shifted the immune response away from an immediate type response (IgE/IgG1) to IgG2a, IgG2b and IgG3. Although both protocols of SEB treatment did not lead to a major deletion of the Vβ8 T cell population, they did reduce the proliferative response of Vβ8+ T cells to OVA. These data indicate that the bacterial toxin SEB is capable of modifying the immediate hypersensitivity response induced by OVA by altering the functional capacity of antigen-reactive Vβ8 T cells. 相似文献
4.
Katrin Gaardbo Kuhn Anne Kathrine Hvass Annette Hartvig Christiansen Steen Ethelberg Susan Alice Cowan 《Emerging infectious diseases》2021,27(4):1133
Campylobacteriosis is a disease of worldwide importance, but aspects of its transmission dynamics, particularly risk factors, are still poorly understood. We used data from a matched case-control study of 4,269 men who have sex with men (MSM) and 26,215 controls, combined with national surveillance data on Campylobacter spp., Salmonella spp., and Shigella spp., to calculate matched odds ratios (mORs) for infection among MSM and controls. MSM had higher odds of Campylobacter (mOR 14, 95% CI 10–21) and Shigella (mOR 74, 95% CI 27–203) infections, but not Salmonella (mOR 0.2, 95% CI 0–13), and were less likely than controls to have acquired Campylobacter infection abroad (χ2 = 21; p<0.001). Our results confirm that sexual contact is a risk factor for campylobacteriosis and also suggest explanations for unique features of Campylobacter epidemiology. These findings provide a baseline for updating infection risk guidelines to the general population. 相似文献
5.
6.
- Repaglinide, a novel compound with a nonsulphonylurea structure, is currently being clinically tested as a therapeutic agent. In the present study, the hypoglycaemic effects of repaglinide in rats and dogs were investigated.
- Whereas the R-enantiomer, AG-EE 624 ZW, showed only weak hypoglycaemic activity, the S-enantiomer, repaglinide, turned out to be a potent hypoglycaemic compound in rats after oral as well as after intravenous administration. Only 50% of the dose of repaglinide was needed to be equieffective with the racemic mixture AG-EE 388 ZW. The corresponding ED50 values calculated for the effects after 120 min p.a. (intravenous administration) were 3.4 μg kg−1 (repaglinide) and 6 μg kg−1 (AG-EE 388 ZW).
- When compared to glimepiride or glibenclamide, repaglinide displayed a 18 to 25 times higher potency in fasted rats. The ED50 values calculated for the effects after 120 min p.a. (oral administration) were 10 μg kg−1 (repaglinide), 182 μg kg−1 (glimepiride) and 255 μg kg−1 (glibenclamide).
- In glucose loaded rats (0.5, 1.0, 2.0 and 3.0 g kg−1 glucose, p.o.) repaglinide exerted a very strong antihyperglycaemic activity which was even more pronounced than under normoglycaemic conditions. So for a reduction in blood glucose of 1 mmol l−1, 10.3, 9.3, 7.0 8.4 and 7.2 μg kg−1 repaglinide were needed after glucose loads of 0.0, 0.5, 1.0, 2.0 and 3.0 g kg−1, respectively.
- In beagle dogs repaglinide again showed a pronounced hypoglycaemic effect (ED50 28.3 μg kg−1) which lasted for up to 24 h. However, insulin levels were only transiently increased.
- The in vivo data presented are well supported by recently published in vitro findings. From its activity profile, repaglinide appears to be a promising new therapeutic agent.
7.
Ilona Krey Sarah von Spiczak Kathrine M. Johannesen Christiane Hikel Gerhard Kurlemann Hiltrud Muhle Diane Beysen Tobias Dietel Rikke S. Mller Johannes R. Lemke Steffen Syrbe 《Neurotherapeutics》2022,19(1):334
Pathogenic missense variants in GRIN2A and GRIN2B may result in gain or loss of function (GoF/LoF) of the N-methyl-D-aspartate receptor (NMDAR). This observation gave rise to the hypothesis of successfully treating GRIN-related disorders due to LoF variants with co-agonists of the NMDAR. In this respect, we describe a retrospectively collected series of ten individuals with GRIN2A- or GRIN2B-related disorders who were treated with L-serine, each within an independent n-of-1 trial. Our cohort comprises one individual with a LoF missense variant with clinical improvements confirming the above hypothesis and replicating a previous n-of-1 trial. A second individual with a GoF missense variant was erroneously treated with L-serine and experienced immediate temporary behavioral deterioration further supporting the supposed functional pathomechanism. Eight additional individuals with null variants (that had been interpreted as loss-of-function variants despite not being missense) again showed clinical improvements. Among all nine individuals with LoF missense or null variants, L-serine treatment was associated with improvements in behavior in eight (89%), in development in four (44%), and/or in EEG or seizure frequency in four (44%). None of these nine individuals experienced side effects or adverse findings in the context of L-serine treatment. In summary, we describe the first evidence that L-serine treatment may not only be associated with clinical improvements in GRIN-related disorders due to LoF missense but particularly also null variants.Supplementary InformationThe online version contains supplementary material available at 10.1007/s13311-021-01173-9. 相似文献
8.
The release of oxytocin and vasopressin from rat neurointermediate lobes was determined in vitro. The electrically evoked release of posterior pituitary hormones was markedly potentiated by the GABA receptor agonist, isogauvacin, an effect which was abolished by the GABAA receptor antagonist bicuculline. Spontaneous hormone outflow was not affected by the substances tested. The results suggest the existence of a GABA receptor on the terminal fibres in the pituitary, facilitating the release of oxytocin and vasopressin. 相似文献
9.
10.